Chlamydia trachomatis (TMA)
Use
The APTIMA Combo 2 Assay for Chlamydia trachomatis/Neisseria gonorrhoeae Assay is an in vitro qualitative nucleic acid amplification test cleared by the FDA for the detection of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) in clinician collected specimens for screening of symptomatic and asymptomatic individuals for evidence of chlamydial and/or gonococcal urogenital disease.
Special Instructions
Urine in preservative-free urine collection cup: Void first 10mL. Stated turn-around-times (TATs) are for clinical use only and subject to change based on biopharma protocol requirements.
Limitations
The performance of the test may vary based on the specimen type and the presence of inhibitors. Compliance with specimen stability and transportation instructions is necessary to ensure valid results.
FDA Approved
Methodology
PCR-based (TMA)
Biomarkers
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
3mL
Minimum Volume
Not provided
Container
ThinPrep® or SurePath™
Storage Instructions
2°C to 25°C
Causes for Rejection
Insufficient specimen volume